HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,016 | -99.6% | 56 | -99.6% | 0.00% | -100.0% |
| Q2 2023 | $1,133,128 | -12.9% | 13,309 | -15.3% | 0.00% | -33.3% |
| Q1 2023 | $1,300,499 | -58.3% | 15,716 | -60.3% | 0.01% | -64.7% |
| Q4 2022 | $3,115,562 | +72.9% | 39,613 | +62.8% | 0.02% | +54.5% |
| Q3 2022 | $1,802,000 | +16.8% | 24,335 | +2.8% | 0.01% | 0.0% |
| Q2 2022 | $1,543,000 | -46.2% | 23,670 | -8.4% | 0.01% | -75.6% |
| Q1 2021 | $2,867,000 | -9.1% | 25,827 | -26.7% | 0.04% | -2.2% |
| Q2 2020 | $3,155,000 | +1302.2% | 35,224 | +1702.7% | 0.05% | +557.1% |
| Q4 2019 | $225,000 | -12.5% | 1,954 | -8.5% | 0.01% | -88.5% |
| Q2 2019 | $257,000 | +29.1% | 2,135 | +23.1% | 0.06% | +134.6% |
| Q3 2018 | $199,000 | +397.5% | 1,735 | +293.4% | 0.03% | +4.0% |
| Q2 2018 | $40,000 | – | 441 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |